Novartis, China’s Gan & Lee push into insulin amid diabetes epidemic

Swiss drugmaker Novartis aims to become a big player in supplying insulin to swelling numbers of diabetics, signing a deal with China’s Gan & Lee on versions of three blockbuster brands as the U.S. government is seeking to slash insulin costs. https://kfgo.com/news/articles/2018/dec/19/novartis-links-with-chinas-gan-lee-in-global-insulin-push/